Gonzalez-Gomez J, Estrada-Soto S, Gaona-Tovar E, Gonzalez-Trujano M, Villasana-Salazar B, Narvaez-Gonzalez H
Heliyon. 2025; 11(4):e42701.
PMID: 40040966
PMC: 11876865.
DOI: 10.1016/j.heliyon.2025.e42701.
Anthwal T, Pant S, Rana P, Nain S
Front Chem. 2025; 12:1515866.
PMID: 40012830
PMC: 11861159.
DOI: 10.3389/fchem.2024.1515866.
Kalra S, Bhatia S, Al Harrasi A, Mohan S, Sachdeva H, Sharma D
Scientifica (Cairo). 2024; 2024:8052659.
PMID: 39610870
PMC: 11602530.
DOI: 10.1155/2024/8052659.
Li X, Shi W, Zhao Z, Matsuura T, Lu J, Che J
Adv Sci (Weinh). 2024; 11(39):e2308444.
PMID: 39225597
PMC: 11497107.
DOI: 10.1002/advs.202308444.
Patil R, Kumar S, Acharya S, Karwa V, Shaikh S, Kothari M
Cureus. 2024; 16(7):e64901.
PMID: 39156332
PMC: 11330678.
DOI: 10.7759/cureus.64901.
In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy.
Lv X, Wang J, Yuan Y, Pan L, Liu Q, Guo J
Sci Rep. 2024; 14(1):16562.
PMID: 39020064
PMC: 11254927.
DOI: 10.1038/s41598-024-67594-6.
A Real-World Safety Profile in Neurological, Skin, and Sexual Disorders of Anti-Seizure Medications Using the Pharmacovigilance Database of the Korea Adverse Event Reporting System (KAERS).
Kim D, Lee S
J Clin Med. 2024; 13(13).
PMID: 38999547
PMC: 11242241.
DOI: 10.3390/jcm13133983.
Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine's Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes.
Yin X, Cicali B, Rodriguez-Vera L, Lukacova V, Cristofoletti R, Schmidt S
Pharmaceutics. 2024; 16(6).
PMID: 38931859
PMC: 11206836.
DOI: 10.3390/pharmaceutics16060737.
The long-term outcomes of patients with negative prolonged ambulatory electroencephalography tests: A cross-sectional follow-up study.
Ouchida S, Nikpour A, Zhang X, Faulkner H, Senturias M, Reid N
Health Open Res. 2024; 5:26.
PMID: 38708033
PMC: 11065127.
DOI: 10.12688/healthopenres.13351.1.
Analysis of the action mechanisms and targets of herbal anticonvulsants highlights opportunities for therapeutic engagement with refractory epilepsy.
Tabassum S, Shorter S, Ovsepian S
J Mol Med (Berl). 2024; 102(6):761-771.
PMID: 38653825
PMC: 11106186.
DOI: 10.1007/s00109-024-02445-5.
Schiff Bases: A Captivating Scaffold with Potential Anticonvulsant Activity.
Sahu R, Shah K
Mini Rev Med Chem. 2024; 24(18):1632-1650.
PMID: 38629363
DOI: 10.2174/0113895575302197240408121537.
Time-Series Anomaly Detection Based on Dynamic Temporal Graph Convolutional Network for Epilepsy Diagnosis.
Wu G, Yu K, Zhou H, Wu X, Su S
Bioengineering (Basel). 2024; 11(1).
PMID: 38247930
PMC: 11154349.
DOI: 10.3390/bioengineering11010053.
Feasibility of therapeutic Chinese massage (tui na) for peripheral neuropathy among people with human immunodeficiency virus: findings of a pilot randomized controlled trial.
Ge S, Dune L, Liu M, Fu G, Ma H, Hu J
Front Neurol. 2023; 14:1148150.
PMID: 38107641
PMC: 10722432.
DOI: 10.3389/fneur.2023.1148150.
Cubosomes as versatile lipid nanocarriers for neurological disorder therapeutics: a comprehensive review.
Vahab S, Nair A, Raj D, G P A, P P S, Kumar V
Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(6):3729-3746.
PMID: 38095651
DOI: 10.1007/s00210-023-02879-7.
Discriminative-stimulus effects of cannabidiol oil in Sprague-Dawley rats.
Chalme R, Frankot M, Anderson K
Behav Pharmacol. 2023; 35(1):36-46.
PMID: 38085665
PMC: 10922827.
DOI: 10.1097/FBP.0000000000000762.
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review.
Singh K, Bhushan B, Chanchal D, Sharma S, Rani K, Yadav M
Behav Neurol. 2023; 2023:8825358.
PMID: 37868743
PMC: 10586905.
DOI: 10.1155/2023/8825358.
Nanotechnology-based Nose-to-brain Delivery in Epilepsy: A NovelApproach to Diagnosis and Treatment.
Khan J, Yadav S
Pharm Nanotechnol. 2023; 12(4):314-328.
PMID: 37818558
DOI: 10.2174/0122117385265554230919070402.
The efficacy and safety of first-line anti-seizure medications as substitution therapy for children with drug-resistant epilepsy: a randomized controlled trial protocol.
Perdani R, Arozal W, Mangunatmadja I, Kaswandani N, Handryastuti S, Medise B
Front Neurol. 2023; 14:1237183.
PMID: 37609651
PMC: 10440385.
DOI: 10.3389/fneur.2023.1237183.
Hybridization of the effective pharmacophores for treatment of epilepsy: design, synthesis, in vivo anticonvulsant activity, and in silico studies of phenoxyphenyl-1,3,4-oxadiazole-thio-N-phenylacetamid hybrids.
Fakhrioliaei A, Abedinifar F, Salehi Darjani P, Mohammadi-Khanaposhtani M, Larijani B, Ahangar N
BMC Chem. 2023; 17(1):80.
PMID: 37461080
PMC: 10353189.
DOI: 10.1186/s13065-023-01000-6.
Effect of Linker Elongation on the VGSC Affinity and Anticonvulsant Activity among 4-Alkyl-5-aryl-1,2,4-triazole-3-thione Derivatives.
Paruch K, Kapron B, Luszczki J, Paneth A, Plech T
Molecules. 2023; 28(13).
PMID: 37446948
PMC: 10343781.
DOI: 10.3390/molecules28135287.